gmx1777
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2007 (NCT00457574)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
NAMPT inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N/C#N)NCCCCCCOc2ccc(Cl)cc2)cc1.[Cl-]- Mol. weight
- 672.61 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Prodrug
Sources
- ChEMBLCHEMBL190412 ↗
Also known as
- 1-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxycarbonyloxymethyl)-4-(n'-cyano-n''-(6-(4-chlorophenoxy)hexyl)-n-guanidino)pyridinium
- 1-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxycarbonyloxymethyl)-4-(n'-cyano-n''-(6-(4-chlorophenoxy)hexyl)-n-guanidino)pyridinium chloride
- eb1627
- eb 1627
- eb-1627
- eb-1627
- eb-1627
- gmx1777
- gmx1777
- gmx1777
- gmx1777
- gmx1777
- gmx 1777
- gmx-1777
- teglarinad chloride
- teglarinad chloride
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00457574 | Phase 1 | Mar 1, 2007 | Gemin X |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gemin X | For profit | 1 | 1 | 1 | 2007 |
1 organizations
Page 1 / 1